Srinivasaraghavan K. Kannan

30 Biopolis Street
Matrix, 138671, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Discovery of Pan-TEAD Inhibitors That Disrupt YAP-TEAD Interaction as a Potential Therapy for Gastric Cancers and Mutant KRAS and EGFR Lung Cancers.

Discovery of Pan-TEAD Inhibitors That Disrupt YAP-TEAD Interaction as a Potential Therapy for Gastric Cancers and Mutant KRAS and EGFR Lung Cancers.

Journal: ACS medicinal chemistry letters

Published: October 12, 2025

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

Journal: Cancer gene therapy

Published: July 30, 2025

Conserved leucine-rich repeat proteins in the adhesive projectile slime of velvet worms.

Conserved leucine-rich repeat proteins in the adhesive projectile slime of velvet worms.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 18, 2025

Author Correction: Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists.

Author Correction: Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists.

Journal: Nature communications

Published: February 13, 2025

Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3D.

Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3D.

Journal: Nature communications

Published: December 23, 2024

Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.

Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.

Journal: Clinical and translational medicine

Published: September 23, 2024

Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.

Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.

Journal: EMBO reports

Published: April 16, 2024

Rarγ -Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.

Rarγ -Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.

Journal: bioRxiv : the preprint server for biology

Published: March 18, 2024

Mechanisms of biased agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor.

Mechanisms of biased agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor.

Journal: Science signaling

Published: February 13, 2024

DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11.

DOK3 promotes atopic dermatitis by enabling the phosphatase PP4C to inhibit the T cell signaling mediator CARD11.

Journal: Science signaling

Published: October 31, 2023

Expanding the DNA editing toolbox: Novel lambda integrase variants targeting microalgal and human genome sequences.

Expanding the DNA editing toolbox: Novel lambda integrase variants targeting microalgal and human genome sequences.

Journal: PloS one

Published: September 20, 2023

Stitched peptides as potential cell permeable inhibitors of oncogenic DAXX protein.

Stitched peptides as potential cell permeable inhibitors of oncogenic DAXX protein.

Journal: RSC chemical biology

Published: August 13, 2023

Showing 1-12 of 67

Last Updated: 09/26/2026